Abstract
A set of substituted piperazinyloxazolidinone derivatives has been studied for their antibacterial activity in a few gram-positive bacteria. The structural modifications have provided a superior compound than linezolid, the only drug of this class in the market at present.
Keywords: 3-(4-piperazinophenyl); cinnamoyl group; eperezolid; in vitro MIC; linezolid; molecular modeling; novel antibacterials; oxazolidinones
Conference
International Symposium on the Chemistry of Natural Products and the 4th International Congress on Biodiversity, International Conference on Biodiversity, International Symposium on the Chemistry of Natural Products, ICOB, ISCNP, Biodiversity, Natural Products, 24th, Delhi, India, 2004-01-26–2004-01-31
Published Online: 2009-01-01
Published in Print: 2005-01-01
© 2013 Walter de Gruyter GmbH, Berlin/Boston